Press Releases

CurePSP 2021 International Research Symposium

Dr. Nasser Zawia, founder of NeurTau Inc. and Professor of Pharmacology at University of Rhode Island, has been invited as a Featured Speaker to present at the 2021 CurePSP International Research Symposium featuring leaders from academia and industry to discuss clinical and preclinical science relevant to PSP and tauopathies. Please read here for more information about the event. CurePSP conducts this International Research Symposium to bring together international investigators to hear about and discuss the latest scientific advances relevant to neurodegeneration with a particular focus on rare tauopathies.

Publications and Presentations

Tolfenamic Acid: A Modifier of the Tau Protein and its Role in Cognition and Tauopathy

In this study, treatment with tolfenamic acid  improved spatial learning deficits and memory impairments in young and aged hTau mice along with reductions in total tau as well as in site specific hyperphosphorylation of tau. Furthermore immunohistochemical analysis for phosphorylated tau protein revealed reduced staining in the frontal cortex, hippocampus, and striatum in animals treated […]

NeuroTau, Inc. is a biotech company, formed in 2017, that focuses on developing drugs that target the disruption or decay of the important neurobiological protein called Tau

Contact Us

Close Bitnami banner